NASH DAVID 4
4 · ANI PHARMACEUTICALS INC · Filed Jun 8, 2018
Insider Transaction Report
Form 4
NASH DAVID
Director
Transactions
- Award
Stock Options
2018-06-06+2,225→ 2,225 totalExercise: $65.86Exp: 2028-06-05→ Common Stock (2,225 underlying) - Award
Common Stock
2018-06-06+1,800→ 1,800 total
Footnotes (1)
- [F1]The restricted stock and stock options are subject to vesting, and 50% of the restricted stock and stock options vest on May 17, 2019, and the remaining 50% of the restricted stock and stock options vest on May 17, 2020.